{"id":718514,"date":"2020-11-16T12:00:00","date_gmt":"2020-11-16T12:00:00","guid":{"rendered":"https:\/\/www.pm360online.com\/?guid=c14c431c5f28ebac252b9d59d18bfbf8"},"modified":"2020-11-16T12:00:00","modified_gmt":"2020-11-16T12:00:00","slug":"mereo-biopharma-to-hold-virtual-rd-day-on-tuesday-november-24-2020","status":"publish","type":"post","link":"https:\/\/www.pm360online.com\/mereo-biopharma-to-hold-virtual-rd-day-on-tuesday-november-24-2020\/","title":{"rendered":"Mereo BioPharma to Hold Virtual R&amp;D Day on Tuesday, November 24, 2020"},"content":{"rendered":"<p><![CDATA[LONDON and REDWOOD CITY, Calif., Nov.  16, 2020  (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH) (\u201cMereo\u201d or \u201cthe Company\u201d), a clinical stage biopharmaceutical company focused on oncology and rare diseases, today announced it will host a virtual R&amp;D day on Tuesday, November 24, to review the Company\u2019s key pipeline programs including etigilimab (Anti-TIGIT) for solid tumors and alvelestat for alpha-1 antitrypsin deficiency (AATD) and COVID-19 respiratory disease. The virtual R&amp;D day will feature external experts and will include a more detailed review of the etigilimab development program, including the design and biomarker strategy for the recently initiated Phase 1b\/2 basket combination study.]]><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":74553,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[71350,71363],"tags":[],"_links":{"self":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/posts\/718514"}],"collection":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/users\/74553"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/comments?post=718514"}],"version-history":[{"count":0,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/posts\/718514\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/media?parent=718514"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/categories?post=718514"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/tags?post=718514"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}